UPMC 4
4 · Werewolf Therapeutics, Inc. · Filed May 4, 2021
Insider Transaction Report
Form 4
UPMC
10% Owner
Transactions
- Conversion
Series B Preferred Stock
2021-05-04−2,373,701→ 0 total→ Common Stock (273,811 underlying) - Conversion
Common Stock
2021-05-04+823,945→ 823,945 total - Conversion
Series A Preferred Stock
2021-05-04−7,142,857→ 0 total→ Common Stock (823,945 underlying) - Conversion
Common Stock
2021-05-04+273,811→ 1,097,756 total
Footnotes (2)
- [F1]On May 4, 2021, the Series A Preferred Stock automatically converted into Common Stock on a 8.6691-for-one basis without payment of further consideration upon closing of the initial public offering of the Issuer's common stock. The shares had no expiration date.
- [F2]On May 4, 2021, the Series B Preferred Stock automatically converted into Common Stock on a 8.6691-for-one basis without payment of further consideration upon closing of the initial public offering of the Issuer's common stock. The shares had no expiration date.